TICKERNOMICS Sign up
Last Update: 2024-03-28 02:13:31
MERRIMACK PHARMACEUTICALS INC ( MACK ) https://www.merrimack.com
14.72USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
MACK
21.65%
SPY
32.74%
MACK
126.46%
SPY
92.93%
MACK
492.52%
SPY
224.41%
MACK
322.48%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
210.82
198.00
0.10
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-167.71
1.40
11.25
-1.08
0.00
-81.35
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
100.45
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
7.3659
-14.81
-11.18
0.83
Other Earnings and Cash Flow Stats:
MERRIMACK PHARMACEUTICALS INC ( MACK ) Net Income TTM ($MM) is -1.18
MERRIMACK PHARMACEUTICALS INC ( MACK ) Operating Income TTM ($MM) is -2.09
MERRIMACK PHARMACEUTICALS INC ( MACK ) Owners' Earnings Annual ($MM) is 0.00
MERRIMACK PHARMACEUTICALS INC ( MACK ) Current Price to Owners' Earnings ratio is 0.00
MERRIMACK PHARMACEUTICALS INC ( MACK ) EBITDA TTM ($MM) is -2.55
MERRIMACK PHARMACEUTICALS INC ( MACK ) EBITDA Margin is 0.00%
Capital Allocation:
MERRIMACK PHARMACEUTICALS INC ( MACK ) has paid 0.00 dividends per share and bought back -0.827 million shares in the past 12 months
MERRIMACK PHARMACEUTICALS INC ( MACK ) has increased its debt by 0.0 million USD in the last 12 months
Capital Structure:
MERRIMACK PHARMACEUTICALS INC ( MACK ) Interest-bearing Debt ($MM) as of last quarter is 0
MERRIMACK PHARMACEUTICALS INC ( MACK ) Annual Working Capital Investments ($MM) are 0
MERRIMACK PHARMACEUTICALS INC ( MACK ) Book Value ($MM) as of last quarter is 18
MERRIMACK PHARMACEUTICALS INC ( MACK ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
MERRIMACK PHARMACEUTICALS INC ( MACK ) has 5 million in cash on hand as of last quarter
MERRIMACK PHARMACEUTICALS INC ( MACK ) has 0 million of liabilities due within 12 months, and long term debt 0 as of last quarter
MERRIMACK PHARMACEUTICALS INC ( MACK ) has 14 common shares outstanding as of last quarter
MERRIMACK PHARMACEUTICALS INC ( MACK ) has 0 million USD of preferred stock value
Academic Scores:
MERRIMACK PHARMACEUTICALS INC ( MACK ) Altman Z-Score is 247.60 as of last quarter
MERRIMACK PHARMACEUTICALS INC ( MACK ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
MERRIMACK PHARMACEUTICALS INC ( MACK ) largest shareholder is owning shares at 0.00 ($MM) value
Eric Andersen(an insider) Bought 857 shares of MERRIMACK PHARMACEUTICALS INC ( MACK ) for the amount of $11440.95 on 2023-12-28
1.20% of MERRIMACK PHARMACEUTICALS INC ( MACK ) is held by insiders, and 59.28% is held by institutions
MERRIMACK PHARMACEUTICALS INC ( MACK ) went public on 2012-03-29
Other MERRIMACK PHARMACEUTICALS INC ( MACK ) financial metrics:
FCF:-1.24
Unlevered Free Cash Flow:-2.99
EPS:-0.08
Operating Margin:100.45
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-5.95
Beta:0.83
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About MERRIMACK PHARMACEUTICALS INC ( MACK ) :
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.